Device exchange from Heartmate II to HeartWare HVAD

Rachel A. Beaupre, Ahmed Alnajar, Tadahisa Sugiura, Brendan Chou, Harveen K. Lamba, Chitaru Kurihara, Masashi Kawabori, Andre C. Critsinelis, Adriana Santiago, Jeffrey A. Morgan

Research output: Contribution to journalArticle

Abstract

Background: Despite technological advancements, pump durability and pump-related complications continue to affect and adversely impact the lives of patients with end-stage heart failure on left ventricular assist device (LVAD) support. In an attempt to avoid recurrent LVAD-related complications, there may be circumstances where it is clinically advantageous to exchange a patient's device from HeartMate II to HeartWare HVAD. However, there is a paucity of data that describes the safety and feasibility of such an approach. Objective: We present the largest single-center series of HeartMate II (HMII) to HeartWare (HVAD) device exchanges. Methods: A retrospective review of 11 patients who underwent HMII to HVAD exchange from 2012 to 2017 was conducted to evaluate patient characteristics, incidence of postoperative complications, and survival. Results: Eleven male patients (mean age 55 ± 14.4 years) underwent HMII to HVAD device exchange. One patient expired on postoperative day 7 secondary to sepsis. One patient was lost-to-follow-up after 23 months. An additional three patients died at 5, 7, and 24 months. Mean follow-up after device exchange was 1555 ± 311 days for the remaining six patients. None of the 11 study patients underwent LVAD explant, further device exchange, or heart transplant. Conclusion: Exchange of an HMII LVAD to an HVAD can be performed safely with acceptable perioperative morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)1204-1207
Number of pages4
JournalJournal of Cardiac Surgery
Volume34
Issue number11
DOIs
StatePublished - Nov 1 2019
Externally publishedYes

Fingerprint

Equipment and Supplies
Heart-Assist Devices
Lost to Follow-Up
Sepsis
Heart Failure
Morbidity
Transplants
Safety
Survival
Mortality
Incidence

Keywords

  • heart failure
  • HeartMate II
  • HeartWare HVAD
  • LVAD
  • mechanical circulatory support
  • ventricular assist device
  • ventricular assist device

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Beaupre, R. A., Alnajar, A., Sugiura, T., Chou, B., Lamba, H. K., Kurihara, C., ... Morgan, J. A. (2019). Device exchange from Heartmate II to HeartWare HVAD. Journal of Cardiac Surgery, 34(11), 1204-1207. https://doi.org/10.1111/jocs.14229

Device exchange from Heartmate II to HeartWare HVAD. / Beaupre, Rachel A.; Alnajar, Ahmed; Sugiura, Tadahisa; Chou, Brendan; Lamba, Harveen K.; Kurihara, Chitaru; Kawabori, Masashi; Critsinelis, Andre C.; Santiago, Adriana; Morgan, Jeffrey A.

In: Journal of Cardiac Surgery, Vol. 34, No. 11, 01.11.2019, p. 1204-1207.

Research output: Contribution to journalArticle

Beaupre, RA, Alnajar, A, Sugiura, T, Chou, B, Lamba, HK, Kurihara, C, Kawabori, M, Critsinelis, AC, Santiago, A & Morgan, JA 2019, 'Device exchange from Heartmate II to HeartWare HVAD', Journal of Cardiac Surgery, vol. 34, no. 11, pp. 1204-1207. https://doi.org/10.1111/jocs.14229
Beaupre RA, Alnajar A, Sugiura T, Chou B, Lamba HK, Kurihara C et al. Device exchange from Heartmate II to HeartWare HVAD. Journal of Cardiac Surgery. 2019 Nov 1;34(11):1204-1207. https://doi.org/10.1111/jocs.14229
Beaupre, Rachel A. ; Alnajar, Ahmed ; Sugiura, Tadahisa ; Chou, Brendan ; Lamba, Harveen K. ; Kurihara, Chitaru ; Kawabori, Masashi ; Critsinelis, Andre C. ; Santiago, Adriana ; Morgan, Jeffrey A. / Device exchange from Heartmate II to HeartWare HVAD. In: Journal of Cardiac Surgery. 2019 ; Vol. 34, No. 11. pp. 1204-1207.
@article{787d0e4687dd4f64a96ed2cd6b5a90a8,
title = "Device exchange from Heartmate II to HeartWare HVAD",
abstract = "Background: Despite technological advancements, pump durability and pump-related complications continue to affect and adversely impact the lives of patients with end-stage heart failure on left ventricular assist device (LVAD) support. In an attempt to avoid recurrent LVAD-related complications, there may be circumstances where it is clinically advantageous to exchange a patient's device from HeartMate II to HeartWare HVAD. However, there is a paucity of data that describes the safety and feasibility of such an approach. Objective: We present the largest single-center series of HeartMate II (HMII) to HeartWare (HVAD) device exchanges. Methods: A retrospective review of 11 patients who underwent HMII to HVAD exchange from 2012 to 2017 was conducted to evaluate patient characteristics, incidence of postoperative complications, and survival. Results: Eleven male patients (mean age 55 ± 14.4 years) underwent HMII to HVAD device exchange. One patient expired on postoperative day 7 secondary to sepsis. One patient was lost-to-follow-up after 23 months. An additional three patients died at 5, 7, and 24 months. Mean follow-up after device exchange was 1555 ± 311 days for the remaining six patients. None of the 11 study patients underwent LVAD explant, further device exchange, or heart transplant. Conclusion: Exchange of an HMII LVAD to an HVAD can be performed safely with acceptable perioperative morbidity and mortality.",
keywords = "heart failure, HeartMate II, HeartWare HVAD, LVAD, mechanical circulatory support, ventricular assist device, ventricular assist device",
author = "Beaupre, {Rachel A.} and Ahmed Alnajar and Tadahisa Sugiura and Brendan Chou and Lamba, {Harveen K.} and Chitaru Kurihara and Masashi Kawabori and Critsinelis, {Andre C.} and Adriana Santiago and Morgan, {Jeffrey A.}",
year = "2019",
month = "11",
day = "1",
doi = "10.1111/jocs.14229",
language = "English (US)",
volume = "34",
pages = "1204--1207",
journal = "Journal of Cardiac Surgery",
issn = "0886-0440",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Device exchange from Heartmate II to HeartWare HVAD

AU - Beaupre, Rachel A.

AU - Alnajar, Ahmed

AU - Sugiura, Tadahisa

AU - Chou, Brendan

AU - Lamba, Harveen K.

AU - Kurihara, Chitaru

AU - Kawabori, Masashi

AU - Critsinelis, Andre C.

AU - Santiago, Adriana

AU - Morgan, Jeffrey A.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Background: Despite technological advancements, pump durability and pump-related complications continue to affect and adversely impact the lives of patients with end-stage heart failure on left ventricular assist device (LVAD) support. In an attempt to avoid recurrent LVAD-related complications, there may be circumstances where it is clinically advantageous to exchange a patient's device from HeartMate II to HeartWare HVAD. However, there is a paucity of data that describes the safety and feasibility of such an approach. Objective: We present the largest single-center series of HeartMate II (HMII) to HeartWare (HVAD) device exchanges. Methods: A retrospective review of 11 patients who underwent HMII to HVAD exchange from 2012 to 2017 was conducted to evaluate patient characteristics, incidence of postoperative complications, and survival. Results: Eleven male patients (mean age 55 ± 14.4 years) underwent HMII to HVAD device exchange. One patient expired on postoperative day 7 secondary to sepsis. One patient was lost-to-follow-up after 23 months. An additional three patients died at 5, 7, and 24 months. Mean follow-up after device exchange was 1555 ± 311 days for the remaining six patients. None of the 11 study patients underwent LVAD explant, further device exchange, or heart transplant. Conclusion: Exchange of an HMII LVAD to an HVAD can be performed safely with acceptable perioperative morbidity and mortality.

AB - Background: Despite technological advancements, pump durability and pump-related complications continue to affect and adversely impact the lives of patients with end-stage heart failure on left ventricular assist device (LVAD) support. In an attempt to avoid recurrent LVAD-related complications, there may be circumstances where it is clinically advantageous to exchange a patient's device from HeartMate II to HeartWare HVAD. However, there is a paucity of data that describes the safety and feasibility of such an approach. Objective: We present the largest single-center series of HeartMate II (HMII) to HeartWare (HVAD) device exchanges. Methods: A retrospective review of 11 patients who underwent HMII to HVAD exchange from 2012 to 2017 was conducted to evaluate patient characteristics, incidence of postoperative complications, and survival. Results: Eleven male patients (mean age 55 ± 14.4 years) underwent HMII to HVAD device exchange. One patient expired on postoperative day 7 secondary to sepsis. One patient was lost-to-follow-up after 23 months. An additional three patients died at 5, 7, and 24 months. Mean follow-up after device exchange was 1555 ± 311 days for the remaining six patients. None of the 11 study patients underwent LVAD explant, further device exchange, or heart transplant. Conclusion: Exchange of an HMII LVAD to an HVAD can be performed safely with acceptable perioperative morbidity and mortality.

KW - heart failure

KW - HeartMate II

KW - HeartWare HVAD

KW - LVAD

KW - mechanical circulatory support

KW - ventricular assist device

KW - ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=85071612418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071612418&partnerID=8YFLogxK

U2 - 10.1111/jocs.14229

DO - 10.1111/jocs.14229

M3 - Article

C2 - 31478230

AN - SCOPUS:85071612418

VL - 34

SP - 1204

EP - 1207

JO - Journal of Cardiac Surgery

JF - Journal of Cardiac Surgery

SN - 0886-0440

IS - 11

ER -